Daily Archives

July 7, 2017

Denis Corin, CEO of Q BioMed, talks about the future plans for the company which includes a new drug application. Q BioMed was formulated as an acceleration company to go and source innovative undervalued biotechnology assets in the pharmaceutical…
Read More...